8-K
filed May 21, 2026, 7:35 PM ET
ticker ZTS
CIK 0001555280
other material
confidence high
sentiment neutral
materiality 0.25
Zoetis director Louise Parent retires; annual meeting approves all management proposals
Zoetis Inc.
- Director Louise M. Parent retired effective May 20, 2026 under company retirement policy.
- All 12 director nominees elected with votes for ranging from 330M to 356M.
- Say-on-pay approved with 306.3M for vs 51.6M against (85.8% support).
- Shareholders voted 353.4M for holding say-on-pay every year.
- Shareholder proposal to permit written consent failed: 167.3M for, 190.2M against.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001555280-26-000029
- form_type
- 8-K
- ticker
- ZTS
- cik
- 0001555280
- company_name
- Zoetis Inc.
- filed_at
- 2026-05-21T23:35:48+00:00
- discovered_at
- 2026-05-22T10:05:00.289136+00:00
- generated_at
- 2026-05-22T10:08:33.707149+00:00
- sec_items
- ["5.02", "5.07"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.25
- calibrated_materiality_score
- 0.25
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001555280-26-000029
- json_url
- https://secwatch.observer/filing/0001555280-26-000029.json
- markdown_url
- https://secwatch.observer/filing/0001555280-26-000029.md
- text_url
- https://secwatch.observer/filing/0001555280-26-000029.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1555280/000155528026000029/0001555280-26-000029-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1555280/000155528026000029/zts-20260520.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
SYRE
Spyre Therapeutics stockholders approve amended ESPP; director Peter Harwin resigns
Spyre Therapeutics, Inc.
May 29, 2026, 4:45 PM ET
other_material
Items 5.02, 5.07, 9.01
same fact type: executive_change
same SEC item: 5.02, 5.07
same event type: other_material
similar materiality
This filing
Effective May 20, 2026, Ms. Louise M. Parent retired from the Board of Directors of Zoetis Inc. (the “Company”), prior to the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”) in accordance with the Company’s director retirement policy.
Comparable filing
In addition, effective as of May 27, 2026, Peter Harwin resigned from the Board.
Filing page
SEC filing
FULT
Director Martin retires; all proposals pass at Fulton annual meeting
FULTON FINANCIAL CORP
May 28, 2026, 12:18 PM ET
other_material
Items 5.02, 5.07
same fact type: executive_change
same SEC item: 5.02, 5.07
same event type: other_material
similar materiality
This filing
Effective May 20, 2026, Ms. Louise M. Parent retired from the Board of Directors of Zoetis Inc. (the “Company”), prior to the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”) in accordance with the Company’s director retirement policy.
Comparable filing
George K. Martin, a director of Fulton, did not stand for re-election to Fulton’s Board of Directors (the “Board”) at the Annual Meeting and retired from the Board effective immediately after the Annual Meeting.
Filing page
SEC filing
LIXT
Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
June 1, 2026, 8:55 AM ET
other_material
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: other_material
This filing
Effective May 20, 2026, Ms. Louise M. Parent retired from the Board of Directors of Zoetis Inc. (the “Company”), prior to the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”) in accordance with the Company’s director retirement policy.
Comparable filing
On May 29, 2026, the Board of Directors (the “Board”) of Lixte Biotechnology Holdings, Inc., (the “Company”), appointed Stuart D. Porter to serve as a member of the Board, effective May 29, 2026 with a term expiring at the Company’s 2026 Annual Meeting of Stockholders.
Filing page
SEC filing
ELOX
Eloxx Pharma: 1-for-11 reverse stock split effective May 29; appoints two independent directors
Eloxx Pharmaceuticals, Inc.
June 1, 2026, 7:00 AM ET
other_material
Items 3.02, 3.03, 5.03, 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: other_material
This filing
Effective May 20, 2026, Ms. Louise M. Parent retired from the Board of Directors of Zoetis Inc. (the “Company”), prior to the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”) in accordance with the Company’s director retirement policy.
Comparable filing
the Board of Directors (the “Board”) of Eloxx Pharmaceuticals, Inc. (the “Company”) appointed Stephen W. Webster and Nina Kjellson to fill vacancies on the Board
Filing page
SEC filing
FDXF
FedEx Freight completes spin-off from FedEx; $600M drawn, new board and executives appointed
FedEx Freight Holding Company, Inc.
June 1, 2026, 6:46 AM ET
other_material
Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 8.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: other_material
This filing
Effective May 20, 2026, Ms. Louise M. Parent retired from the Board of Directors of Zoetis Inc. (the “Company”), prior to the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”) in accordance with the Company’s director retirement policy.
Comparable filing
each of John A. Smith, R. Brad Martin, Jeffrey A. Davis, Donald E. Frieson, Stephen E. Gorman, Robert A. King, Cindy J. Miller, Amy J. Salcido, and Samantha M. Smith was appointed to the Board
Filing page
SEC filing
FXAC
FortuneX Acquisition closes IPO of 8.625M units at $10/unit, raising $86.25M gross
FortuneX Acquisition Corp
May 29, 2026, 5:32 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: other_material
This filing
Effective May 20, 2026, Ms. Louise M. Parent retired from the Board of Directors of Zoetis Inc. (the “Company”), prior to the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”) in accordance with the Company’s director retirement policy.
Comparable filing
Effective May 19, 2026, in connection with the effectiveness of the Company’s Registration Statement, Becky Fallon, Sean Michael Deegan, and Robert Labbe became members of the board of directors (the “Board”) of the Company.
Filing page
SEC filing
CRMT
America's Car-Mart forms special committee for strategic alternatives; appoints new independent director
AMERICAS CARMART INC
May 29, 2026, 5:30 PM ET
other_material
Items 1.01, 5.02, 8.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: other_material
This filing
Effective May 20, 2026, Ms. Louise M. Parent retired from the Board of Directors of Zoetis Inc. (the “Company”), prior to the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”) in accordance with the Company’s director retirement policy.
Comparable filing
On May 22, 2026, the Board increased the size of the Board from nine members to ten members and appointed Adam Paul as an independent director, effective immediately.
Filing page
SEC filing
MVST
Microvast CEO converts $25M loan to equity; CAO Eric Garcia departs
Microvast Holdings, Inc.
May 28, 2026, 5:26 PM ET
other_material
Items 5.02, 8.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: other_material
This filing
Effective May 20, 2026, Ms. Louise M. Parent retired from the Board of Directors of Zoetis Inc. (the “Company”), prior to the Company’s 2026 Annual Meeting of Shareholders (the “Annual Meeting”) in accordance with the Company’s director retirement policy.
Comparable filing
On May 27, 2026, Eric N. Garcia ceased to be employed as Chief Accounting Officer of Microvast Holdings, Inc. (the “Company”).
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.